This inventor holds 2 USPTO granted patents. Top assignees: Massachusetts Institute of Technology, Other. Active years: 2007-2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Helsinki 96, FI (2007)
- Helsinki, FI (2008)
Company Filing History:
1 out of 8,578 
1 out of 834,453 Years Active: 2007-2008
Title: Helena E Miettinen: Pioneering Innovations in Atherosclerosis and Infertility Treatments
Introduction
Helena E Miettinen is a distinguished inventor based in Helsinki, Finland. She has made significant contributions to the fields of cardiovascular health and reproductive biology. With a total of 2 patents, her work focuses on innovative treatments for atherosclerosis and infertility.
Latest Patents
Miettinen's latest patents include groundbreaking research on the screening of compounds for the treatment of atherosclerosis and heart attack. Her work with transgenic animals has revealed that those lacking functional SR-BI and ApoE develop severe atherosclerosis by the age of four weeks. These animals also exhibit progressive heart dysfunction and have a high mortality rate by nine weeks. This animal model has proven useful for screening compounds that alleviate symptoms of atherosclerosis and heart disease. In another patent, she explored lipid-altering compositions for treating infertility. Her research indicates that SR-BI is crucial for the fertility of female animals, and her findings suggest that fertility can be restored through specific manipulations of plasma lipoproteins.
Career Highlights
Throughout her career, Miettinen has worked at prestigious institutions, including the Massachusetts Institute of Technology. Her research has garnered attention for its innovative approach to complex health issues, particularly in understanding the mechanisms behind atherosclerosis and infertility.
Collaborations
Miettinen has collaborated with notable scientists such as Monty Krieger and Anne Braun. These partnerships have furthered her research and contributed to the advancement of knowledge in her fields of expertise.
Conclusion
Helena E Miettinen's contributions to medical research are invaluable, particularly in the areas of cardiovascular health and reproductive biology. Her innovative patents and collaborative efforts continue to pave the way for future advancements in these critical fields.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile